Ultragenyx Pharma (RARE) – Analyst Ratings
-
Stifel Lays Out Biotech Names Exposure to SVB Financial Group (SIVB)
-
Canaccord Genuity Assumes Ultragenyx Pharma (RARE) at Buy
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to RARE Stock Lookup